{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T08:30:31Z","timestamp":1768725031452,"version":"3.49.0"},"publisher-location":"Cham","reference-count":63,"publisher":"Springer International Publishing","isbn-type":[{"value":"9783030870157","type":"print"},{"value":"9783030870164","type":"electronic"}],"license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2021]]},"DOI":"10.1007\/978-3-030-87016-4_30","type":"book-chapter","created":{"date-parts":[[2021,9,11]],"date-time":"2021-09-11T06:02:42Z","timestamp":1631340162000},"page":"398-412","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":17,"title":["Multilayered Modelling of the Metallation of Biological Targets"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9700-5331","authenticated-orcid":false,"given":"Iogann","family":"Tolbatov","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8311-8172","authenticated-orcid":false,"given":"Alessandro","family":"Marrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5325-9452","authenticated-orcid":false,"given":"Roberto","family":"Paciotti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0957-4049","authenticated-orcid":false,"given":"Nazzareno","family":"Re","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3609-290X","authenticated-orcid":false,"given":"Cecilia","family":"Coletti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2021,9,12]]},"reference":[{"issue":"4972","key":"30_CR1","doi-asserted-by":"publisher","first-page":"698","DOI":"10.1038\/205698a0","volume":"205","author":"B Rosenberg","year":"1965","unstructured":"Rosenberg, B., Van Camp, L., Krigas, T.: Inhibition of cell division in escherichia coli by electrolysis products from a platinum electrode. Nature 205(4972), 698\u2013699 (1965). https:\/\/doi.org\/10.1038\/205698a0","journal-title":"Nature"},{"key":"30_CR2","doi-asserted-by":"publisher","first-page":"102925","DOI":"10.1016\/j.bioorg.2019.102925","volume":"88","author":"S Ghosh","year":"2019","unstructured":"Ghosh, S.: Cisplatin: The first metal based anticancer drug. Bioorg. Chem. 88, 102925 (2019). https:\/\/doi.org\/10.1016\/j.bioorg.2019.102925","journal-title":"Bioorg. Chem."},{"issue":"9","key":"30_CR3","doi-asserted-by":"publisher","first-page":"2467","DOI":"10.1021\/cr980421n","volume":"99","author":"ER Jamieson","year":"1999","unstructured":"Jamieson, E.R., Lippard, S.J.: Structure, recognition, and processing of cisplatin\u2212DNA adducts. Chem. Rev. 99(9), 2467\u20132498 (1999). https:\/\/doi.org\/10.1021\/cr980421n","journal-title":"Chem. Rev."},{"issue":"3","key":"30_CR4","doi-asserted-by":"publisher","first-page":"451","DOI":"10.1016\/S0162-0134(02)00472-5","volume":"91","author":"DB Zamble","year":"2002","unstructured":"Zamble, D.B., Mikata, Y., Eng, C.H., Sandman, K.E., Lippard, S.J.: Testis-specific HMG-domain protein alters the responses of cells to cisplatin. J. Inorg. Biochem. 91(3), 451\u2013462 (2002). https:\/\/doi.org\/10.1016\/S0162-0134(02)00472-5","journal-title":"J. Inorg. Biochem."},{"issue":"8","key":"30_CR5","doi-asserted-by":"publisher","first-page":"4540","DOI":"10.1021\/cr400460s","volume":"114","author":"KD Mjos","year":"2014","unstructured":"Mjos, K.D., Orvig, C.: Metallodrugs in medicinal inorganic chemistry. Chem. Rev. 114(8), 4540\u20134563 (2014). https:\/\/doi.org\/10.1021\/cr400460s","journal-title":"Chem. Rev."},{"issue":"1","key":"30_CR6","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0010-8545(98)00192-1","volume":"182","author":"B Lippert","year":"1999","unstructured":"Lippert, B.: Impact of cisplatin on the recent development of Pt coordination chemistry: a case study. Coord. Chem. Rev. 182(1), 263\u2013295 (1999). https:\/\/doi.org\/10.1016\/S0010-8545(98)00192-1","journal-title":"Coord. Chem. Rev."},{"key":"30_CR7","doi-asserted-by":"publisher","unstructured":"Paciotti, R., Tolbatov, I., Graziani, V., Marrone, A., Re, N., Coletti, C.: Insights on the activity of platinum-based anticancer complexes through computational methods. In: AIP Conference Proceedings, vol. 2040, p. 020019:1\u20134. AIP Publishing LLC (2018). doi: https:\/\/doi.org\/10.1063\/1.5079061","DOI":"10.1063\/1.5079061"},{"key":"30_CR8","doi-asserted-by":"publisher","unstructured":"Paciotti, R., Tolbatov, I., Marrone, A., Storchi, L., Re, N., Coletti, C.: Computational investigations of bioinorganic complexes: The case of calcium, gold and platinum ions. In: AIP Conference Proceedings, vol. 2186, issue 1, p. 030011:1\u20134. AIP Publishing LLC (2019). doi: https:\/\/doi.org\/10.1063\/1.5137922","DOI":"10.1063\/1.5137922"},{"key":"30_CR9","doi-asserted-by":"publisher","first-page":"3631","DOI":"10.1021\/jz401959s","volume":"4","author":"A De Petris","year":"2013","unstructured":"De Petris, A., et al.: Vibrational signatures of the naked aqua complexes from platinum(II) anticancer drugs. J. Phys. Chem. Lett. 4, 3631\u20133635 (2013). https:\/\/doi.org\/10.1021\/jz401959s","journal-title":"J. Phys. Chem. Lett."},{"key":"30_CR10","doi-asserted-by":"publisher","first-page":"15877","DOI":"10.1039\/C7RA01182B","volume":"7","author":"D Corinti","year":"2017","unstructured":"Corinti, D., et al.: Hydrolysis of cis- and transplatin: structure and reactivity of the aqua complexes in a solvent free environment. RSC Adv. 7, 15877\u201315884 (2017). https:\/\/doi.org\/10.1039\/C7RA01182B","journal-title":"RSC Adv."},{"key":"30_CR11","doi-asserted-by":"publisher","first-page":"71","DOI":"10.1002\/jcc.24920","volume":"39","author":"MDR Cuevas-Flores","year":"2018","unstructured":"Cuevas-Flores, M.D.R., Garcia-Revilla, M.A., Bartolomei, M.: Noncovalent interactions between cisplatin and graphene prototypes. J. Comp. Chem. 39, 71\u201380 (2018). https:\/\/doi.org\/10.1002\/jcc.24920","journal-title":"J. Comp. Chem."},{"key":"30_CR12","doi-asserted-by":"publisher","first-page":"1074","DOI":"10.3390\/nano10061074","volume":"10","author":"MR Cuevas-Flores","year":"2020","unstructured":"Cuevas-Flores, M.R., Bartolomei, M., Garc\u00eda-Revilla, M.A., Coletti, C.: Interaction and reactivity of cisplatin physisorbed on graphene oxide nano-prototypes. Nanomaterials 10, 1074 (2020). https:\/\/doi.org\/10.3390\/nano10061074","journal-title":"Nanomaterials"},{"issue":"24","key":"30_CR13","doi-asserted-by":"publisher","first-page":"13827","DOI":"10.1021\/ic402611m","volume":"52","author":"L Messori","year":"2013","unstructured":"Messori, L., Marzo, T., Gabbiani, C., Valdes, A.A., Quiroga, A.G., Merlino, A.: Peculiar features in the crystal structure of the adduct formed between cis-PtI2(NH3)2 and hen egg white lysozyme. Inorg. Chem. 52(24), 13827\u201313829 (2013). https:\/\/doi.org\/10.1021\/ic402611m","journal-title":"Inorg. Chem."},{"key":"30_CR14","doi-asserted-by":"publisher","first-page":"111096","DOI":"10.1016\/j.jinorgbio.2020.111096","volume":"209","author":"I Tolbatov","year":"2020","unstructured":"Tolbatov, I., et al.: Reactions of cisplatin and cis-[PtI2(NH3)2] with molecular models of relevant protein sidechains: a comparative analysis. J. Inorg. Biochem. 209, 111096 (2020). https:\/\/doi.org\/10.1016\/j.jinorgbio.2020.111096","journal-title":"J. Inorg. Biochem."},{"key":"30_CR15","doi-asserted-by":"publisher","first-page":"182","DOI":"10.1016\/j.jinorgbio.2013.04.010","volume":"127","author":"T Parro","year":"2013","unstructured":"Parro, T., et al.: The second generation of iodido complexes: trans-[PtI2(amine)(amine\u2032)] bearing different aliphatic amines. J. Inorg. Biochem. 127, 182\u2013187 (2013). https:\/\/doi.org\/10.1016\/j.jinorgbio.2013.04.010","journal-title":"J. Inorg. Biochem."},{"key":"30_CR16","doi-asserted-by":"publisher","first-page":"26697","DOI":"10.1039\/C7CP05203K","volume":"19","author":"R Paciotti","year":"2017","unstructured":"Paciotti, R., et al.: Cisplatin and transplatin interaction with methionine: bonding motifs assayed by vibrational spectroscopy in the isolated ionic complexes. Phys. Chem. Chem. Phys. 19, 26697\u201326707 (2017). https:\/\/doi.org\/10.1039\/C7CP05203K","journal-title":"Phys. Chem. Chem. Phys."},{"key":"30_CR17","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/cphc.201601172","volume":"18","author":"D Corinti","year":"2017","unstructured":"Corinti, D., et al.: Cisplatin primary complex with l-histidine target revealed by IR multiple photon dissociation (IRMPD) spectroscopy. ChemPhysChem 18, 318\u2013325 (2017). https:\/\/doi.org\/10.1002\/cphc.201601172","journal-title":"ChemPhysChem"},{"issue":"11","key":"30_CR18","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.2174\/1568026615666150915111434","volume":"16","author":"I Tomassoli","year":"2016","unstructured":"Tomassoli, I., G\u00fcndisch, D.: Bispidine as a privileged scaffold. Curr. Top. Med. Chem. 16(11), 1314\u20131342 (2016)","journal-title":"Curr. Top. Med. Chem."},{"issue":"27","key":"30_CR19","doi-asserted-by":"publisher","first-page":"5175","DOI":"10.1021\/acs.jpca.6b00844","volume":"120","author":"V Graziani","year":"2016","unstructured":"Graziani, V., Coletti, C., Marrone, A., Re, N.: Activation and reactivity of a bispidine analogue of cisplatin: A theoretical investigation. J. Phys. Chem. A 120(27), 5175\u20135186 (2016). https:\/\/doi.org\/10.1021\/acs.jpca.6b00844","journal-title":"J. Phys. Chem. A"},{"key":"30_CR20","doi-asserted-by":"publisher","unstructured":"Cui, H., Goddard, R., P\u00f6rschke, K.R., Hamacher, A., Kassack, M.U.: Bispidine analogues of cisplatin, carboplatin, and oxaliplatin. Synthesis, structures, and cytotoxicity. Inorg. Chem. 53(7), 3371\u20133384 (2014). doi: https:\/\/doi.org\/10.1021\/ic402737f","DOI":"10.1021\/ic402737f"},{"key":"30_CR21","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1016\/j.critrevonc.2016.03.014","volume":"102","author":"GY Ho","year":"2016","unstructured":"Ho, G.Y., Woodward, N., Coward, J.I.: Cisplatin versus carboplatin: comparative review of therapeutic management in solid malignancies. Crit. Rev. Oncol. Hematol. 102, 37\u201346 (2016). https:\/\/doi.org\/10.1016\/j.critrevonc.2016.03.014","journal-title":"Crit. Rev. Oncol. Hematol."},{"issue":"6","key":"30_CR22","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.3892\/or.10.6.1663","volume":"10","author":"T Boulikas","year":"2003","unstructured":"Boulikas, T., Vougiouka, M.: Cisplatin and platinum drugs at the molecular level. Oncol. Rep. 10(6), 1663\u20131682 (2003). https:\/\/doi.org\/10.3892\/or.10.6.1663","journal-title":"Oncol. Rep."},{"issue":"6","key":"30_CR23","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s00214-011-0933-9","volume":"129","author":"A Ciancetta","year":"2011","unstructured":"Ciancetta, A., Coletti, C., Marrone, A., Re, N.: Activation of carboplatin by chloride ions: a theoretical investigation. Theor. Chem. Acc. 129(6), 757\u2013769 (2011). https:\/\/doi.org\/10.1007\/s00214-011-0933-9","journal-title":"Theor. Chem. Acc."},{"issue":"41","key":"30_CR24","doi-asserted-by":"publisher","first-page":"12960","DOI":"10.1039\/C2DT30556A","volume":"41","author":"A Ciancetta","year":"2012","unstructured":"Ciancetta, A., Coletti, C., Marrone, A., Re, N.: Activation of carboplatin by carbonate: a theoretical investigation. Dalton Trans. 41(41), 12960\u201312969 (2012). https:\/\/doi.org\/10.1039\/C2DT30556A","journal-title":"Dalton Trans."},{"key":"30_CR25","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/j.ica.2012.01.028","volume":"389","author":"AJ Di Pasqua","year":"2012","unstructured":"Di Pasqua, A.J., Goodisman, J., Dabrowiak, J.C.: Understanding how the platinum anticancer drug carboplatin works: from the bottle to the cell. Inorganica Chim. Acta 389, 29\u201335 (2012). https:\/\/doi.org\/10.1016\/j.ica.2012.01.028","journal-title":"Inorganica Chim. Acta"},{"issue":"1","key":"30_CR26","doi-asserted-by":"publisher","first-page":"7","DOI":"10.13005\/bpj\/1608","volume":"12","author":"SA Aldossary","year":"2019","unstructured":"Aldossary, S.A.: Review on pharmacology of cisplatin: clinical use, toxicity and mechanism of resistance of cisplatin. Biomed. Pharmacol. J. 12(1), 7\u201315 (2019). https:\/\/doi.org\/10.13005\/bpj\/1608","journal-title":"Biomed. Pharmacol. J."},{"issue":"1","key":"30_CR27","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41467-019-08290-2","volume":"10","author":"A Yimit","year":"2019","unstructured":"Yimit, A., Adebali, O., Sancar, A., Jiang, Y.: Differential damage and repair of DNA-adducts induced by anti-cancer drug cisplatin across mouse organs. Nature Comm. 10(1), 1\u201311 (2019). https:\/\/doi.org\/10.1038\/s41467-019-08290-2","journal-title":"Nature Comm."},{"key":"30_CR28","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.jinorgbio.2012.06.013","volume":"117","author":"E Wexselblatt","year":"2012","unstructured":"Wexselblatt, E., Gibson, D.: What do we know about the reduction of Pt (IV) pro-drugs? J. Inorg. Biochem. 117, 220\u2013229 (2012). https:\/\/doi.org\/10.1016\/j.jinorgbio.2012.06.013","journal-title":"J. Inorg. Biochem."},{"issue":"6","key":"30_CR29","doi-asserted-by":"publisher","first-page":"3411","DOI":"10.1021\/acs.inorgchem.8b00177","volume":"57","author":"I Tolbatov","year":"2018","unstructured":"Tolbatov, I., Coletti, C., Marrone, A., Re, N.: Insight into the electrochemical reduction mechanism of Pt (IV) anticancer complexes. Inorg. Chem. 57(6), 3411\u20133419 (2018). https:\/\/doi.org\/10.1021\/acs.inorgchem.8b00177","journal-title":"Inorg. Chem."},{"issue":"3","key":"30_CR30","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1039\/c8mt00306h","volume":"11","author":"C Schmidt","year":"2019","unstructured":"Schmidt, C., et al.: A gold (I) biscarbene complex with improved activity as a TrxR inhibitor and cytotoxic drug: comparative studies with different gold metallodrugs. Metallomics 11(3), 533\u2013545 (2019). https:\/\/doi.org\/10.1039\/c8mt00306h","journal-title":"Metallomics"},{"issue":"2","key":"30_CR31","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1039\/C2CS35314H","volume":"42","author":"W Liu","year":"2013","unstructured":"Liu, W., Gust, R.: Metal N-heterocyclic carbene complexes as potential antitumor metallodrugs. Chem. Soc. Rev. 42(2), 755\u2013773 (2013). https:\/\/doi.org\/10.1039\/C2CS35314H","journal-title":"Chem. Soc. Rev."},{"issue":"5\u20136","key":"30_CR32","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1155\/MBD.1994.395","volume":"1","author":"GG Graham","year":"1994","unstructured":"Graham, G.G., Champion, G.D., Ziegler, J.B.: The cellular metabolism and effects of gold complexes. Met. Based Drugs 1(5\u20136), 395\u2013404 (1994)","journal-title":"Met. Based Drugs"},{"issue":"4","key":"30_CR33","doi-asserted-by":"publisher","first-page":"820","DOI":"10.3390\/ijms20040820","volume":"20","author":"I Tolbatov","year":"2019","unstructured":"Tolbatov, I., Coletti, C., Marrone, A., Re, N.: Reactivity of gold (I) monocarbene complexes with protein targets: a theoretical study. Int. J. Mol. Sci. 20(4), 820 (2019). https:\/\/doi.org\/10.3390\/ijms20040820","journal-title":"Int. J. Mol. Sci."},{"key":"30_CR34","doi-asserted-by":"publisher","first-page":"161","DOI":"10.1016\/j.jinorgbio.2014.01.009","volume":"136","author":"A Pratesi","year":"2014","unstructured":"Pratesi, A., et al.: Insights on the mechanism of thioredoxin reductase inhibition by gold N-heterocyclic carbene compounds using the synthetic linear selenocysteine containing C-terminal peptide hTrxR (488\u2013499): an ESI-MS investigation. J. Inorg. Biochem. 136, 161\u2013169 (2014). https:\/\/doi.org\/10.1016\/j.jinorgbio.2014.01.009","journal-title":"J. Inorg. Biochem."},{"issue":"5","key":"30_CR35","doi-asserted-by":"publisher","first-page":"3312","DOI":"10.1021\/acs.inorgchem.0c00106","volume":"59","author":"I Tolbatov","year":"2020","unstructured":"Tolbatov, I., Coletti, C., Marrone, A., Re, N.: Insight into the substitution mechanism of antitumor Au (I) N-heterocyclic carbene complexes by cysteine and selenocysteine. Inorg. Chem. 59(5), 3312\u20133320 (2020). https:\/\/doi.org\/10.1021\/acs.inorgchem.0c00106","journal-title":"Inorg. Chem."},{"issue":"38","key":"30_CR36","doi-asserted-by":"publisher","first-page":"12570","DOI":"10.1021\/ja804027j","volume":"130","author":"JL Hickey","year":"2008","unstructured":"Hickey, J.L., Ruhayel, R.A., Barnard, P.J., Baker, M.V., Berners-Price, S.J., Filipovska, A.: Mitochondria-targeted chemotherapeutics: the rational design of gold (I) N-heterocyclic carbene complexes that are selectively toxic to cancer cells and target protein selenols in preference to thiols. J. Am. Chem. Soc. 130(38), 12570\u201312571 (2008). https:\/\/doi.org\/10.1021\/ja804027j","journal-title":"J. Am. Chem. Soc."},{"key":"30_CR37","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1016\/j.biochi.2019.03.015","volume":"162","author":"X Zhang","year":"2019","unstructured":"Zhang, X., et al.: Repurposing of auranofin: thioredoxin reductase remains a primary target of the drug. Biochimie 162, 46\u201354 (2019). https:\/\/doi.org\/10.1016\/j.biochi.2019.03.015","journal-title":"Biochimie"},{"issue":"6","key":"30_CR38","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s10787-012-0149-1","volume":"20","author":"JM Madeira","year":"2012","unstructured":"Madeira, J.M., Gibson, D.L., Kean, W.F., Klegeris, A.: The biological activity of auranofin: implications for novel treatment of diseases. Inflammopharmacology 20(6), 297\u2013306 (2012). https:\/\/doi.org\/10.1007\/s10787-012-0149-1","journal-title":"Inflammopharmacology"},{"issue":"4","key":"30_CR39","doi-asserted-by":"publisher","first-page":"656","DOI":"10.1021\/acsmedchemlett.9b00007","volume":"10","author":"T Marzo","year":"2019","unstructured":"Marzo, T., et al.: Replacement of the thiosugar of auranofin with iodide enhances the anticancer potency in a mouse model of ovarian cancer. ACS Med. Chem. Lett. 10(4), 656\u2013660 (2019). https:\/\/doi.org\/10.1021\/acsmedchemlett.9b00007","journal-title":"ACS Med. Chem. Lett."},{"key":"30_CR40","doi-asserted-by":"publisher","first-page":"812","DOI":"10.3389\/fchem.2020.00812","volume":"8","author":"I Tolbatov","year":"2020","unstructured":"Tolbatov, I., et al.: Mechanistic insights into the anticancer properties of the auranofin analog Au(PEt3)I: a theoretical and experimental study. Front. Chem. 8, 812 (2020). https:\/\/doi.org\/10.3389\/fchem.2020.00812","journal-title":"Front. Chem."},{"key":"30_CR41","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1007\/s00775-009-0558-9","volume":"14","author":"A Casini","year":"2009","unstructured":"Casini, A., et al.: Chemistry, antiproliferative properties, tumor selectivity, and molecular mechanisms of novel gold(III) compounds for cancer treatment: a systematic study. J. Biol. Inorg. Chem. 14, 1139\u20131149 (2009). https:\/\/doi.org\/10.1007\/s00775-009-0558-9","journal-title":"J. Biol. Inorg. Chem."},{"key":"30_CR42","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1128\/MCB.01482-07","volume":"28","author":"M Hara-Chikuma","year":"2008","unstructured":"Hara-Chikuma, M., Verkman, A.S.: Prevention of skin tumorigenesis and impairment of epidermal cell proliferation by targeted aquaporin-3 gene disruption. Mol. Cell Biol. 28, 326\u2013332 (2008). https:\/\/doi.org\/10.1128\/MCB.01482-07","journal-title":"Mol. Cell Biol."},{"issue":"55","key":"30_CR43","doi-asserted-by":"publisher","first-page":"13802","DOI":"10.1002\/chem.201703092","volume":"23","author":"V Graziani","year":"2017","unstructured":"Graziani, V., Marrone, A., Re, N., Coletti, C., Platts, J.A., Casini, A.: A multilevel theoretical study to disclose the binding mechanisms of gold (III) bipyridyl compounds as selective aquaglyceroporin inhibitors. Chem. Eur. J. 23(55), 13802\u201313813 (2017). https:\/\/doi.org\/10.1002\/chem.201703092","journal-title":"Chem. Eur. J."},{"issue":"3","key":"30_CR44","doi-asserted-by":"publisher","first-page":"2140","DOI":"10.1021\/acs.inorgchem.8b03233","volume":"58","author":"MN Wenzel","year":"2019","unstructured":"Wenzel, M.N., et al.: Insights into the mechanisms of aquaporin-3 inhibition by gold (III) complexes: the importance of non-coordinative adduct formation. Inorg. Chem. 58(3), 2140\u20132148 (2019). https:\/\/doi.org\/10.1021\/acs.inorgchem.8b03233","journal-title":"Inorg. Chem."},{"key":"30_CR45","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1016\/S0010-8545(02)00025-5","volume":"232","author":"MJ Clarke","year":"2002","unstructured":"Clarke, M.J.: Ruthenium metallopharmaceuticals. Coord. Chem. Rev. 232, 69\u201393 (2002). https:\/\/doi.org\/10.1016\/S0010-8545(02)00025-5","journal-title":"Coord. Chem. Rev."},{"key":"30_CR46","doi-asserted-by":"publisher","unstructured":"Ang, W.H., Dyson, P.J.: Classical and non-classical ruthenium-based anticancer drugs: towards targeted chemotherapy. Eur. J. Inorg. Chem. 4003\u22124018 (2006). doi: https:\/\/doi.org\/10.1002\/ejic.200600723","DOI":"10.1002\/ejic.200600723"},{"issue":"33","key":"30_CR47","doi-asserted-by":"publisher","first-page":"9955","DOI":"10.1021\/jp072182q","volume":"111","author":"N Be\u0161ker","year":"2007","unstructured":"Be\u0161ker, N., Coletti, C., Marrone, A., Re, N.: Binding of antitumor ruthenium complexes to DNA and proteins: a theoretical approach. J. Phys. Chem. B 111(33), 9955\u20139964 (2007). https:\/\/doi.org\/10.1021\/jp072182q","journal-title":"J. Phys. Chem. B"},{"issue":"9","key":"30_CR48","doi-asserted-by":"publisher","first-page":"1085","DOI":"10.2174\/092986706776360941","volume":"13","author":"I Kostova","year":"2006","unstructured":"Kostova, I.: Ruthenium complexes as anticancer agents. Curr. Med. Chem. 13(9), 1085\u20131107 (2006). https:\/\/doi.org\/10.2174\/092986706776360941","journal-title":"Curr. Med. Chem."},{"issue":"13","key":"30_CR49","doi-asserted-by":"publisher","first-page":"3871","DOI":"10.1021\/jp800411g","volume":"112","author":"N Be\u0161ker","year":"2008","unstructured":"Be\u0161ker, N., Coletti, C., Marrone, A., Re, N.: Aquation of the ruthenium-based anticancer drug NAMI-A: a density functional study. J. Phys. Chem. B 112(13), 3871\u20133875 (2008). https:\/\/doi.org\/10.1021\/jp800411g","journal-title":"J. Phys. Chem. B"},{"issue":"41","key":"30_CR50","doi-asserted-by":"publisher","first-page":"14520","DOI":"10.1039\/D0DT02527E","volume":"49","author":"E Barresi","year":"2020","unstructured":"Barresi, E., et al.: A mixed-valence diruthenium (II, III) complex endowed with high stability: from experimental evidence to theoretical interpretation. Dalton Trans. 49(41), 14520\u201314527 (2020). https:\/\/doi.org\/10.1039\/D0DT02527E","journal-title":"Dalton Trans."},{"issue":"1","key":"30_CR51","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1093\/jhmas\/jrg042","volume":"59","author":"TG Benedek","year":"2004","unstructured":"Benedek, T.G.: The history of gold therapy for tuberculosis. J. Hist. Med. Allied Sci. 59(1), 50\u201389 (2004). https:\/\/doi.org\/10.1093\/jhmas\/jrg042","journal-title":"J. Hist. Med. Allied Sci."},{"issue":"9","key":"30_CR52","doi-asserted-by":"publisher","first-page":"863","DOI":"10.1039\/c1mt00062d","volume":"3","author":"SJ Berners-Price","year":"2011","unstructured":"Berners-Price, S.J., Filipovska, A.: Gold compounds as therapeutic agents for human diseases. Metallomics 3(9), 863\u2013873 (2011). https:\/\/doi.org\/10.1039\/c1mt00062d","journal-title":"Metallomics"},{"issue":"5","key":"30_CR53","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1111\/j.1365-2958.2007.05590.x","volume":"63","author":"SK Checa","year":"2007","unstructured":"Checa, S.K., Espariz, M., Audero, M.E.P., Botta, P.E., Spinelli, S.V., Soncini, F.C.: Bacterial sensing of and resistance to gold salts. Mol. Microbiol. 63(5), 1307\u20131318 (2007). https:\/\/doi.org\/10.1111\/j.1365-2958.2007.05590.x","journal-title":"Mol. Microbiol."},{"issue":"3","key":"30_CR54","doi-asserted-by":"publisher","first-page":"419","DOI":"10.1007\/s10534-010-9393-2","volume":"24","author":"SK Checa","year":"2011","unstructured":"Checa, S.K., Soncini, F.C.: Bacterial gold sensing and resistance. Biometals 24(3), 419\u2013427 (2011). https:\/\/doi.org\/10.1007\/s10534-010-9393-2","journal-title":"Biometals"},{"issue":"49","key":"30_CR55","doi-asserted-by":"publisher","first-page":"15358","DOI":"10.1021\/jacs.5b09895","volume":"137","author":"W Wei","year":"2015","unstructured":"Wei, W., et al.: Structural insights and the surprisingly low mechanical stability of the Au\u2013S bond in the gold-specific protein GolB. J. Am. Chem. Soc. 137(49), 15358\u201315361 (2015). https:\/\/doi.org\/10.1021\/jacs.5b09895","journal-title":"J. Am. Chem. Soc."},{"issue":"16","key":"30_CR56","doi-asserted-by":"publisher","first-page":"11091","DOI":"10.1021\/acs.inorgchem.9b01604","volume":"58","author":"I Tolbatov","year":"2019","unstructured":"Tolbatov, I., Re, N., Coletti, C., Marrone, A.: An insight on the gold (I) affinity of golB protein via multilevel computational approaches. Inorg. Chem. 58(16), 11091\u201311099 (2019). https:\/\/doi.org\/10.1021\/acs.inorgchem.9b01604","journal-title":"Inorg. Chem."},{"key":"30_CR57","first-page":"1068","volume":"78","author":"S Tong","year":"2000","unstructured":"Tong, S., Schirnding, Y.E.V., Prapamontol, T.: Environmental lead exposure: a public health problem of global dimensions. Bull. World Health Org. 78, 1068\u20131077 (2000)","journal-title":"Bull. World Health Org."},{"issue":"3","key":"30_CR58","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1007\/s002489900145","volume":"37","author":"TM Roane","year":"1999","unstructured":"Roane, T.M.: Lead resistance in two bacterial isolates from heavy metal\u2013contaminated soils. Microb. Ecol. 37(3), 218\u2013224 (1999). https:\/\/doi.org\/10.1007\/s002489900145","journal-title":"Microb. Ecol."},{"issue":"4","key":"30_CR59","doi-asserted-by":"publisher","first-page":"405","DOI":"10.1038\/s41557-020-0423-6","volume":"12","author":"AE Tolbert","year":"2020","unstructured":"Tolbert, A.E., et al.: Heteromeric three-stranded coiled coils designed using a Pb (II)(Cys)3 template mediated strategy. Nature Chem. 12(4), 405\u2013411 (2020). https:\/\/doi.org\/10.1038\/s41557-020-0423-6","journal-title":"Nature Chem."},{"issue":"19","key":"30_CR60","doi-asserted-by":"publisher","first-page":"5651","DOI":"10.1128\/JB.183.19.5651-5658.2001","volume":"183","author":"B Borremans","year":"2001","unstructured":"Borremans, B., Hobman, J.L., Provoost, A., Brown, N.L., van der Lelie, D.: Cloning and functional analysis of the pbr lead resistance determinant of Ralstonia metallidurans CH34. J. Bacteriol. 183(19), 5651\u20135658 (2001). https:\/\/doi.org\/10.1128\/JB.183.19.5651-5658.2001","journal-title":"J. Bacteriol."},{"issue":"24","key":"30_CR61","doi-asserted-by":"publisher","first-page":"12516","DOI":"10.1021\/acs.inorgchem.6b02397","volume":"55","author":"S Huang","year":"2016","unstructured":"Huang, S., et al.: Structural basis for the selective Pb (II) recognition of metalloregulatory protein PbrR691. Inorg. Chem. 55(24), 12516\u201312519 (2016). https:\/\/doi.org\/10.1021\/acs.inorgchem.6b02397","journal-title":"Inorg. Chem."},{"issue":"1","key":"30_CR62","doi-asserted-by":"publisher","first-page":"790","DOI":"10.1021\/acs.inorgchem.9b03059","volume":"59","author":"I Tolbatov","year":"2019","unstructured":"Tolbatov, I., Re, N., Coletti, C., Marrone, A.: Determinants of the Lead (II) affinity in pbrR protein: a computational study. Inorg. Chem. 59(1), 790\u2013800 (2019). https:\/\/doi.org\/10.1021\/acs.inorgchem.9b03059","journal-title":"Inorg. Chem."},{"issue":"2","key":"30_CR63","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s00214-021-02718-z","volume":"140","author":"I Tolbatov","year":"2021","unstructured":"Tolbatov, I., Marrone, A.: Molecular dynamics simulation of the Pb(II) coordination in biological media via cationic dummy atom models. Theoret. Chem. Acc. 140(2), 1\u201312 (2021). https:\/\/doi.org\/10.1007\/s00214-021-02718-z","journal-title":"Theoret. Chem. Acc."}],"container-title":["Lecture Notes in Computer Science","Computational Science and Its Applications \u2013 ICCSA 2021"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-3-030-87016-4_30","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,11]],"date-time":"2021-09-11T06:08:09Z","timestamp":1631340489000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-3-030-87016-4_30"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021]]},"ISBN":["9783030870157","9783030870164"],"references-count":63,"URL":"https:\/\/doi.org\/10.1007\/978-3-030-87016-4_30","relation":{},"ISSN":["0302-9743","1611-3349"],"issn-type":[{"value":"0302-9743","type":"print"},{"value":"1611-3349","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021]]},"assertion":[{"value":"12 September 2021","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}},{"value":"ICCSA","order":1,"name":"conference_acronym","label":"Conference Acronym","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"International Conference on Computational Science and Its Applications","order":2,"name":"conference_name","label":"Conference Name","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Cagliari","order":3,"name":"conference_city","label":"Conference City","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Italy","order":4,"name":"conference_country","label":"Conference Country","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"2021","order":5,"name":"conference_year","label":"Conference Year","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"13 September 2021","order":7,"name":"conference_start_date","label":"Conference Start Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"16 September 2021","order":8,"name":"conference_end_date","label":"Conference End Date","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"21","order":9,"name":"conference_number","label":"Conference Number","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"iccsa2021","order":10,"name":"conference_id","label":"Conference ID","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"https:\/\/iccsa.org\/","order":11,"name":"conference_url","label":"Conference URL","group":{"name":"ConferenceInfo","label":"Conference Information"}},{"value":"Single-blind","order":1,"name":"type","label":"Type","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"Customed version of CyberChair 4","order":2,"name":"conference_management_system","label":"Conference Management System","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"1588","order":3,"name":"number_of_submissions_sent_for_review","label":"Number of Submissions Sent for Review","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"466","order":4,"name":"number_of_full_papers_accepted","label":"Number of Full Papers Accepted","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"18","order":5,"name":"number_of_short_papers_accepted","label":"Number of Short Papers Accepted","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"29% - The value is computed by the equation \"Number of Full Papers Accepted \/ Number of Submissions Sent for Review * 100\" and then rounded to a whole number.","order":6,"name":"acceptance_rate_of_full_papers","label":"Acceptance Rate of Full Papers","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"2,5","order":7,"name":"average_number_of_reviews_per_paper","label":"Average Number of Reviews per Paper","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"8","order":8,"name":"average_number_of_papers_per_reviewer","label":"Average Number of Papers per Reviewer","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}},{"value":"Yes","order":9,"name":"external_reviewers_involved","label":"External Reviewers Involved","group":{"name":"ConfEventPeerReviewInformation","label":"Peer Review Information (provided by the conference organizers)"}}]}}